Table 1.
M ± SD | Range | |
---|---|---|
Age at onset of PANS illness | 7.90 ± 3.44 | 2.21–17.7 |
Flares per patient in dataset | ||
Flares that received no NSAID treatment (Np = 82, Nf = 271) | 3.30 ± 2.77 | 1–13 |
Flares that received early NSAID treatment (Np = 36, Nf = 43) | 1.19 ± 0.58 | 1–4 |
Flares that received prophylactic NSAIDs (Np = 39, Nf = 76) | 1.95 ± 1.10 | 1–5 |
n (%) | ||
---|---|---|
Male | 58/95 (61%) | |
Obsessive-compulsive disorder | 85/95 (89%) | |
Eating restrictiona | 49/94 (52%) | |
Anxiety | 92/95 (97%) | |
Mood dysregulationb | 93/95 (98%) | |
Irritability/oppositionality/aggression | 89/95 (94%) | |
Behavioral regressiona | 71/94 (76%) | |
Academic deteriorationa | 64/91 (70%) | |
Sensory or motor symptoms | 91/95 (96%) | |
Somatic symptoms | 92/95 (97%) |
Some missing data: eating restriction and behavioral regression, n = 1. Academic deterioration, n = 4.
Mood dysregulation, including depression and/or emotional lability.
PANS, Pediatric Acute-onset Neuropsychiatric Syndrome; NSAIDs, nonsteroidal anti-inflammatory drugs; NP, number of patients; NF, number of flares.